Puma Biotechnology Inc (PBYI) Q4 2023 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Puma Biotechnology Inc.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.578 -- 00:00:06.042 Good afternoon. My name is Alicia and I'll be your conference call operator today. 00:00:06.042 -- 00:00:10.265 At this time, all participants are in a listen-only mode. 00:00:10.265 -- 00:00:14.989 After the speaker's formal remarks, there will be a question and answer session. 00:00:14.989 -- 00:00:19.662 If you would like to ask a question during that time, simply press star then the number 00:00:19.662 -- 00:00:24.756 1 on your telephone keypad. If you would like to withdraw your question, please 00:00:24.756 -- 00:00:29.929 press star 2. And if you should require operator assistance during the conference, please 00:00:29.929 -- 00:00:31.890 press star zero. 00:00:31.890 -- 00:00:34.392 As a reminder, this call is being recorded. 00:00:34.392 -- 00:00:39.676 I would now like to turn the conference call over to Marianne O'Hanison, 00:00:39.676 -- 00:00:43.419 Senior Director of IR for PUMA Biotechnology. 00:00:43.419 -- 00:00:46.161 You may begin your conference. 00:00:46.161 -- 00:00:48.402 Thank you, Alicia. 00:00:48.402 -- 00:00:52.786 Good afternoon and welcome to PUMA's conference call to discuss our financial results 00:00:52.786 -- 00:00:55.731 for the fourth quarter of 2023. 00:00:55.731 -- 00:01:00.896 Joining me on the call today are Ellen Auerbach, Chief Executive Officer, President 00:01:00.896 -- 00:01:03.978 and Chairman of the Board of PUMA Biotechnology, 00:01:03.978 -- 00:01:09.043 Maximo Noguez, Chief Financial Officer, and Jeff Ludwig, Chief Commercial 00:01:09.043 -- 00:01:10.944 Officer. 00:01:10.944 -- 00:01:16.629 After market closed today, PUMA issued a news release detailing fourth quarter and full 00:01:16.629 -- 00:01:19.632 year 2023 financial results. 00:01:19.632 -- 00:01:24.755 That news release, t...